The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma.
 
Viranda Jayalath
Stock and Other Ownership Interests - AngioDynamics; Monopar Therapeutics; Novo Nordisk; Recursion Pharmaceuticals
 
Min Yuen Teo
Consulting or Advisory Role - AstraZeneca; Janssen Oncology
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Pharmacyclics (Inst)
 
Melissa Assel
No Relationships to Disclose
 
Daniel Rodriguez
No Relationships to Disclose
 
Abraham Meyerson
No Relationships to Disclose
 
Bernard Bochner
Consulting or Advisory Role - Olympus
 
Guido Dalbagni
No Relationships to Disclose
 
S. Donat
No Relationships to Disclose
 
Harry Herr
No Relationships to Disclose
 
Eugene Cha
No Relationships to Disclose
 
Timothy Donahue
No Relationships to Disclose
 
Eugene Pietzak
Honoraria - UpToDate
Consulting or Advisory Role - Chugai Pharma; Janssen; Merck; QED Therapeutics; Urogen pharma
Research Funding - Janssen
 
A. Hakimi
Consulting or Advisory Role - Merck
 
Kwanghee Kim
Stock and Other Ownership Interests - Arvinas
 
Hikmat Al-Ahmadie
Consulting or Advisory Role - AstraZeneca/MedImmune; PAIGE.AI; Pfizer
 
Hebert Vargas
No Relationships to Disclose
 
Jonathan Rosenberg
Honoraria - Clinical Care Options; MashupMD; Medical Educator Consortium; Medscape; MJH Life Sciences; NCCN/Pfizer; Peerview; Pfizer; Physicans' Education Resource; Research To Practice; Touch Oncology; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Century Therapeutics; EMD Serono; Generate Biomedicines; Gilead Sciences; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer; Roche/Genentech; Samsung Bioepis; Seagen; Tyra Biosciences
Research Funding - Acrivon Therapeutics; Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Lilly; Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Amplification of chromosome 1q23 to predict cancer outcomes (Inst); Predictor of platinum sensitivity (Inst)
Travel, Accommodations, Expenses - Seagen
(OPTIONAL) Uncompensated Relationships - Alliance for Clinical Trials in Oncology
 
Gopa Iyer
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Flare Therapeutics; Janssen; Loxo/Lilly; Mirati Therapeutics
Research Funding - Bayer (Inst); Debiopharm Group (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Seagen (Inst)
 
Dean Bajorin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
 
Jonathan Coleman
Travel, Accommodations, Expenses - Digital Angiography Reading Center (I)
(OPTIONAL) Uncompensated Relationships - AngioDynamics; Steba Biotech